MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-13-2026
FONAR Corporation General and Administrative Expenses 2011-2026 | FONR
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses FONAR Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.5 M | 24.7 M | 26.7 M | 19.3 M | 18.1 M | 19.4 M | 18.5 M | 13.5 M | 15.4 M | 12.5 M | 8.75 M | 8.46 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 26.7 M | 8.46 M | 17.4 M |
Quarterly General and Administrative Expenses FONAR Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.24 M | 6.81 M | 7.99 M | 6.93 M | 5.13 M | 7.59 M | 5.59 M | 4.87 M | 7.14 M | 6.6 M | 6.33 M | 12.9 M | 6.07 M | 4.77 M | 5.09 M | 9.86 M | 6.11 M | 4.54 M | 6.16 M | 4.54 M | 6.16 M | 4.16 M | 4.29 M | 4.16 M | 4.29 M | 3.61 M | 4.26 M | 3.61 M | 4.26 M | 3.29 M | 4.08 M | 3.29 M | 4.08 M | 4.07 M | 4.06 M | 4.07 M | 4.06 M | 3.87 M | 4.19 M | 4.12 M | 3.78 M | 3.82 M | 3.58 M | 3.82 M | 3.58 M | 4.35 M | 3.74 M | 4.35 M | 3.74 M | 2.35 M | 2.21 M | 2.35 M | 2.21 M | 2 M | 2.04 M | 2 M | 2.04 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 12.9 M | 2 M | 4.65 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
499 M | $ 11.9 | -2.06 % | $ 1.79 B |  USA |
 |
Butterfly Network
BFLY
|
39.8 M | $ 4.29 | 2.39 % | $ 908 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
15.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
14.1 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | - | -5.86 % | $ 30.6 M | USA |
 |
BioSig Technologies
BSGM
|
11.6 M | - | 37.08 % | $ 85.7 M | USA |
 |
LivaNova PLC
LIVN
|
549 M | $ 62.99 | -0.4 % | $ 3.44 B |  Britain |
 |
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | USA |
 |
LENSAR
LNSR
|
26.5 M | $ 5.72 | -5.85 % | $ 65.9 M | USA |
 |
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
8.75 M | $ 1.35 | -0.22 % | $ 21.8 M | USA |
 |
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M | USA |
 |
Medtronic PLC
MDT
|
10.8 B | $ 87.15 | -0.07 % | $ 112 B | USA |
 |
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | USA |
 |
AxoGen
AXGN
|
44.6 M | $ 32.23 | 1.51 % | $ 1.48 B | USA |
 |
CONMED Corporation
CNMD
|
132 M | $ 36.47 | -0.44 % | $ 1.13 B | USA |
 |
Soliton, Inc.
SOLY
|
8.46 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
8.5 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Electromed
ELMD
|
39.3 M | $ 24.44 | -0.2 % | $ 207 M | USA |
 |
Misonix, Inc.
MSON
|
18 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
35 M | $ 0.68 | 0.86 % | $ 37 M | USA |
 |
Aethlon Medical
AEMD
|
3.24 M | $ 2.24 | -2.61 % | $ 3.5 M | USA |
 |
BIOLASE
BIOL
|
10.2 M | - | -13.19 % | $ 166 K | USA |
 |
Orthofix Medical
OFIX
|
554 M | $ 11.9 | 0.25 % | $ 471 M |  Curacao |
 |
AdaptHealth Corp.
AHCO
|
382 M | $ 11.04 | 6.41 % | $ 1.49 B | USA |
 |
Myomo
MYO
|
14 M | $ 0.72 | 2.1 % | $ 30.1 M | USA |
 |
IRadimed Corporation
IRMD
|
17.8 M | $ 99.94 | 0.75 % | $ 1.27 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
22.5 M | $ 2.36 | -3.28 % | $ 138 M | Israel |
 |
Invacare Corporation
IVC
|
227 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
5.9 M | $ 3.85 | 3.08 % | $ 144 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
120 M | $ 16.26 | -1.28 % | $ 381 M | USA |
 |
Penumbra
PEN
|
663 M | $ 335.06 | -0.15 % | $ 13 B | USA |
 |
Outset Medical
OM
|
37.9 M | $ 3.51 | -3.04 % | $ 53.4 K | USA |
 |
Inspire Medical Systems
INSP
|
625 M | $ 51.85 | -0.69 % | $ 1.52 B | USA |
 |
Insulet Corporation
PODD
|
1.16 B | $ 225.55 | -0.68 % | $ 15.9 B | USA |
 |
Profound Medical Corp.
PROF
|
10.3 M | $ 5.16 | -4.44 % | $ 180 M | Canada |
 |
Pulmonx Corporation
LUNG
|
101 M | $ 1.38 | -1.08 % | $ 56.1 M | USA |
 |
Quanterix Corporation
QTRX
|
138 M | $ 3.75 | -4.82 % | $ 160 M | USA |
 |
Cutera
CUTR
|
63.3 M | - | -10.19 % | $ 1.99 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.46 M | - | 14.99 % | $ 929 K | USA |
 |
InspireMD
NSPR
|
20.7 M | $ 1.79 | 3.47 % | $ 115 M | Israel |